Importantly, an inverse CD4+ Tconv cells-to-CD4+ Tregs ratio, as well as a higher CD8+ T cell-to-CD4+ Tregs ratio, was observed after KV treatment in the tumor but not in tumor-dLNs (Figure 2C and Figure S1E). The gene discussed is CD8A; the disease is neoplasm.